Status:
RECRUITING
Genomics and Microbiome Investigation in Cases of Recurrent Pregnancy Losses
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborating Sponsors:
UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL (UFRGS)
Conditions:
Recurrent Pregnancy Loss(RPL)
Eligibility:
FEMALE
Brief Summary
Recurrent pregnancy losses (RPL) are characterized by the occurrence of more than one spontaneous pregnancy loss. It is caused by different known factors, but about half of the cases remain without an...
Detailed Description
Recurrent pregnancy losses (RPL) are adverse reproductive outcomes characterized by the occurrence of more than one spontaneous pregnancy loss. It is estimated that RPL occurs in 1 to 5% of couples in...
Eligibility Criteria
Inclusion
- RPL group: history of at least two spontaneous pregnancy losses, regardless of whether they have living children, and whose etiology for the pregnancy losses was not determined by the care team\'s protocols;
- Control group: at least two full-term pregnancies and no history of difficulty getting pregnant, pregnancy loss or other infertility factors.
Exclusion
- RPL group: less than two spontaneous pregnancy losses and those with a known cause for repeated pregnancy losses;
- Control group: N/A
Key Trial Info
Start Date :
April 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06604338
Start Date
April 14 2023
End Date
December 1 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Alegre (HCPA)
Porto Alegre, Rio Grande do Sul, Brazil, 90410-000